English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduExperiments in mice have shown early success in vaccinating them against potentially deadly bacterial infections, such as methicillin-resistant Staphylococcal aureus, or MRSA, the strain resistant to most drug treatments.
Tag: Nyu Langone
Star-Shaped Brain Cells May Play a Critical Role in Glaucoma
After a brain injury, cells that normally nourish nerves may actually kill them instead, a new study in rodents finds. This “reactive” phenomenon may be the driving factor behind neurodegenerative diseases like glaucoma, a leading cause of blindness.
Scientists Decode How the Brain Senses Smell
Scientists have further decoded how mammalian brains perceive odors and distinguish one smell from thousands of others.
New COVID Local Risk Index Helps Cities Identify Neighborhoods at Highest Risk for COVID and Better Target Resources to Blunt Local Pandemic Impact
A new city-oriented COVID Local Risk Index will help municipal leaders identify cities and neighborhoods with populations at higher risk of COVID-19 infection and more severe COVID-19 illness by incorporating key risk factors of race and ethnicity, age, household crowding, poverty and underlying health conditions like diabetes and obesity.
NYU Langone Among First to Enroll Patients In Clinical Trial for COVID-19 Monoclonal Antibody Treatment
The first patients were treated as part of a clinical trial testing whether an antibody therapy can safely reduce COVID-19 disease severity. The experimental treatment consists of identical copies of an antibody, a blood protein related to those that occur naturally as part of the human immune system, researchers say.
Health System in Pandemic Epicenter Identifies Outcomes and New Risk Factors of Patients Hospitalized with COVID-19
A team of investigators at NYU Langone Health determined that just over half of 5,279 patients who tested positive for COVID-19 were hospitalized — and nearly a quarter of those hospitalized died or were discharged to hospice, including 60 percent who required ventilators.
COVID-19 PATIENTS MAY HAVE LOWER STROKE RATES THAN PREVIOUSLY SUGGESTED
Fewer people than previously reported suffer from stroke as a result of COVID-19, a new analysis finds. However, strokes that accompany the pandemic virus, SARS-CoV-2, appear to be more severe.
CELIAC DISEASE LINKED TO COMMON CHEMICAL POLLUTANTS
Elevated blood levels of toxic chemicals found in pesticides, nonstick cookware, and fire retardants have been tied to an increased risk for celiac disease in young people, new research shows.
Telemedicine Transforms Response to COVID-19 Pandemic in Disease Epicenter
A rapid increase in “virtual” visits during the COVID-19 pandemic could transform the way physicians provide care in the United States going forward, according to a new study led by researchers from NYU Grossman School of Medicine.
Clinical Trial To Test Blood Plasma from Recovered Patients as Treatment for COVID-19 Disease
A clinical trial now underway is looking at whether blood plasma donated by people recovered from 2019 coronavirus disease (COVID-19) could be used to treat other people with the pandemic virus.
NYU Langone Scientists Tracking Genetic Evolution of Coronavirus in New York City
As of April 9, NYU Grossman School of Medicine researchers had determined the genetic code for COVID-19 virus taken from 91 New York City patients during the current pandemic, the researchers say.
3D GENETIC STRUCTURE IN BLOOD CANCER IMPORTANT BEYOND DNA CODE CHANGES
Children with aggressive blood cancers have differences — not just in the DNA code of their blood cells — but also in the heavily twisted protein superstructure that controls access to genes.
Melanoma Is Killing Fewest Americans in Decades
Advances in treatment have led to the largest yearly declines in deaths due to melanoma ever recorded for this skin cancer, results of a new study suggest.
Medication Treatments Led to 80 Percent Lower Risk of Fatal Overdose for Patients with Opioid Use Disorder than Medication-free Treatments
Patients with opioid use disorder (OUD) receiving treatment with opioid agonists (medications such as methadone or buprenorphine) had an 80 percent lower risk of dying from an opioid overdose compared to patients in treatment without the use of medications.
Antianxiety and Antidepressant Effects from a Single Dose of Psychedelic Drug Persist Years Later in Cancer Patients
Following up on their landmark 2016 study, researchers at NYU Grossman School of Medicine found that a one-time, single-dose treatment of psilocybin, a compound found in psychedelic mushrooms, combined with psychotherapy appears to be associated with significant improvements in emotional and existential distress in cancer patients.
Flame Retardants and Pesticides Overtake Heavy Metals as Biggest Contributors to IQ Loss
Adverse outcomes from childhood exposures to lead and mercury are on the decline in the United States, likely due to decades of restrictions on the use of heavy metals, a new study finds.
Medicaid Expansion Associated with Fewer Total Opioid Overdose Deaths Across the U.S.
The expansion of Medicaid coverage for low-income adults permitted by the Affordable Care Act (ACA) was associated with a six percent reduction in total opioid overdose deaths nationally, according to new research from NYU Grossman School of Medicine and University of California, Davis.
Computer Game May Help to Predict Reuse of Opioids
A computer betting game can help predict the likelihood that someone recovering from opioid addiction will reuse the pain-relieving drugs, a new study shows.
In States Where Recreational Marijuana is Legal, Adults Use More Frequently and Teens Report Increased Problematic Use
In States Where Recreational Marijuana is Legal,
Adults Use More Frequently and Teens Report Increased Problematic Use
How Far Schoolkids Live From Junk Food Sources Tied to Obesity
As measured in city blocks, proximity to fast and convenience food sellers can impact a student’s chances of becoming obese, according to a new study by researchers at NYU School of Medicine.